BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15186481)

  • 1. Pharmacogenomics arrives.
    Petsko GA
    Genome Biol; 2004; 5(6):108. PubMed ID: 15186481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics: the path to individualised patient care.
    Adelung MR; Fitzsimons VM
    Br J Nurs; 2014 Jul 10-23; 23(13):738-9. PubMed ID: 25072336
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of severe cutaneous adverse reactions.
    Kaniwa N; Saito Y
    Pharmacogenomics; 2013 Apr; 14(6):595-8. PubMed ID: 23570461
    [No Abstract]   [Full Text] [Related]  

  • 5. Implementation of pharmacogenomics in product information.
    Skvrce NM; Krivokapić S; Božina N
    Pharmacogenomics; 2020 May; 21(7):443-448. PubMed ID: 32336208
    [No Abstract]   [Full Text] [Related]  

  • 6. Facilitating clinical implementation of pharmacogenomics.
    Mrazek DA; Lerman C
    JAMA; 2011 Jul; 306(3):304-5. PubMed ID: 21771991
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in the Pharmacogenomics of Adverse Drug Reactions.
    Collins SL; Carr DF; Pirmohamed M
    Drug Saf; 2016 Jan; 39(1):15-27. PubMed ID: 26650062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics and reducing the frequency of adverse drug events.
    O'Kane DJ; Weinshilboum RM; Moyer TP
    Pharmacogenomics; 2003 Jan; 4(1):1-4. PubMed ID: 12517278
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA: a pharmacogenomics success story.
    Becquemont L
    Pharmacogenomics; 2010 Mar; 11(3):277-81. PubMed ID: 20235781
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacogenetics: relevant aspects for the practicing veterinarian].
    Jud Schefer R; Paine Kuhn C; Demuth D
    Schweiz Arch Tierheilkd; 2012 Dec; 154(12):521-7. PubMed ID: 23188764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are we PREPAREd? Concerning the "PREemptive Pharmacogenomics Testing for Preventing Adverse Drug Reactions (PREPARE) Study".
    De Carmo Campos A; Cardoso ML; Vicente A
    Acta Med Port; 2023 Oct; 36(10):689-690. PubMed ID: 37788651
    [No Abstract]   [Full Text] [Related]  

  • 12. Using pharmacogenetics to prevent severe adverse reactions to capecitabine.
    García-González X; López-Fernández LA
    Pharmacogenomics; 2017 Aug; 18(13):1199-1213. PubMed ID: 28746000
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.
    Sleder AT; Kalus J; Lanfear DE
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):20-6. PubMed ID: 26054891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Pharmacogenomics: The Same Medications Do Not Work the Same on Everyone.
    Krau SD
    Nurs Clin North Am; 2016 Mar; 51(1):ix-x. PubMed ID: 26897430
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.
    Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS
    OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine.
    Giacomini KM; Yee SW; Mushiroda T; Weinshilboum RM; Ratain MJ; Kubo M
    Nat Rev Drug Discov; 2017 Jan; 16(1):1. PubMed ID: 27885282
    [No Abstract]   [Full Text] [Related]  

  • 17. Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?
    Huddart R; Sangkuhl K; Whirl-Carrillo M; Klein TE
    Clin Pharmacol Ther; 2019 Aug; 106(2):284-286. PubMed ID: 30977517
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress and Challenges in Pharmacogenomics.
    Van Driest SL; Cascorbi I
    Clin Pharmacol Ther; 2021 Sep; 110(3):529-532. PubMed ID: 34412159
    [No Abstract]   [Full Text] [Related]  

  • 19. Special Section on Pharmacogenomics: recent advances and future directions.
    Mushiroda T; Giacomini KM; Kubo M
    J Hum Genet; 2013 Jun; 58(6):305. PubMed ID: 23797326
    [No Abstract]   [Full Text] [Related]  

  • 20. Conference Scene: Pharmacogenomics at the second PharmSciFair 2009: adverse drug reactions and clinical implementation.
    van Schie RM; Cascorbi I; Maitland-van der Zee AH
    Pharmacogenomics; 2009 Sep; 10(9):1389-91. PubMed ID: 19761363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.